Brown, Lisle/Cummings’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41K Sell
641
-65
-9% -$4.27K 0.01% 423
2026
Q1
$50.3K Buy
706
+160
+29% +$12.6K 0.01% 358
2025
Q4
$44.8K Hold
546
– – 0.01% 355
2025
Q3
$41K Hold
546
– – 0.01% 361
2025
Q2
$40.4K Hold
546
– – 0.01% 357
2025
Q1
$44.1K Sell
546
-59
-10% -$5.07K 0.01% 342
2024
Q4
$47.3K Buy
605
+150
+33% +$12.8K 0.01% 339
2024
Q3
$42.7K Buy
455
+26
+6% +$2.18K 0.01% 330
2024
Q2
$33.4K Hold
429
– – 0.01% 344
2024
Q1
$39K Hold
429
– – 0.01% 314
2023
Q4
$33.2K Sell
429
-147
-26% -$10.3K 0.01% 321
2023
Q3
$39.2K Buy
576
+264
+85% +$19.2K 0.02% 284
2023
Q2
$25.3K Sell
312
-464
-60% -$37K 0.01% 319
2023
Q1
$63.7K Buy
+776
New +$55.4K 0.03% 255

Other funds holding GEHC

Brown, Lisle/Cummings's GEHC Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its GE HealthCare (GEHC) stake by 9.2% in Q2 2026, selling an estimated $4.27K and leaving 641 shares worth $41K. The position accounts for 0.01% of the portfolio, ranked #423.

Brown, Lisle/Cummings first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $63.7K in Q1 2023. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Brown, Lisle/Cummings held 641 shares of GE HealthCare worth $41K as of Q2 2026.
  • Brown, Lisle/Cummings sold 65 GE HealthCare shares in Q2 2026, an estimated $4.27K.
  • GE HealthCare made up 0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #423 holding.
  • Brown, Lisle/Cummings first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Brown, Lisle/Cummings's GE HealthCare position peaked at $63.7K in Q1 2023.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.